Previous close | 163.45 |
Open | 164.45 |
Bid | 156.62 x N/A |
Ask | 171.84 x N/A |
Day's range | 164.45 - 166.35 |
52-week range | 92.98 - 182.72 |
Volume | |
Avg. volume | 157,068 |
Market cap | 295.857B |
Beta (5Y monthly) | 0.47 |
PE ratio (TTM) | 33.84 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 5.92 (4.05%) |
Ex-dividend date | 12 Oct 2023 |
1y target est | N/A |
AbbVie's Richard Gonzalez with 650 Tern Point Circle in Boca Raton (Daniel Petroni, AbbVie)AbbVie CEO Richard Gonzalez is the latest heavy hitter to buy in Boca Raton. The pharma boss dropped $14.3 million on a waterfront mansion, following a string of eight-figure deals in the city. Records show Gonzalez bought the house at 650 Tern Point Circle in Boca Raton’s […]The post AbbVie CEO latest heavy hitter to buy in Boca Raton appeared first on The Real Deal.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out.
AbbVie (ABBV) inks an option-to-license and collaboration deal with Gilgamesh to develop next-generation therapies for psychiatric disorders.